Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

OneMedNet (ONMD) EBIT (2022 - 2025)

Historic EBIT for OneMedNet (ONMD) over the last 4 years, with Q3 2025 value amounting to -$2.2 million.

  • OneMedNet's EBIT rose 432.36% to -$2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.2 million, marking a year-over-year decrease of 546.87%. This contributed to the annual value of -$9.6 million for FY2024, which is 4015.76% down from last year.
  • Per OneMedNet's latest filing, its EBIT stood at -$2.2 million for Q3 2025, which was up 432.36% from -$2.1 million recorded in Q2 2025.
  • In the past 5 years, OneMedNet's EBIT registered a high of -$520025.0 during Q3 2022, and its lowest value of -$4.0 million during Q4 2022.
  • Its 4-year average for EBIT is -$1.9 million, with a median of -$2.1 million in 2025.
  • Within the past 5 years, the most significant YoY rise in OneMedNet's EBIT was 5283.5% (2023), while the steepest drop was 27055.91% (2023).
  • OneMedNet's EBIT (Quarter) stood at -$4.0 million in 2022, then soared by 52.84% to -$1.9 million in 2023, then crashed by 45.4% to -$2.7 million in 2024, then rose by 17.71% to -$2.2 million in 2025.
  • Its last three reported values are -$2.2 million in Q3 2025, -$2.1 million for Q2 2025, and -$2.2 million during Q1 2025.